Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,621 | -4,694 | -3,415 | -1,597 | -358 |
| Depreciation Amortization | 3,722 | 1,851 | 7,278 | 5,431 | 3,582 |
| Income taxes - deferred | 407 | 178 | 336 | 92 | 86 |
| Accounts receivable | 3,458 | 704 | 810 | 1,751 | -68 |
| Accounts payable and accrued liabilities | -269 | 2,039 | -523 | -298 | -270 |
| Other Working Capital | 130 | 1,708 | 4,600 | 2,211 | -1,379 |
| Other Operating Activity | 730 | -383 | 4,942 | 2,135 | 3,771 |
| Operating Cash Flow | $557 | $1,403 | $14,028 | $9,725 | $5,364 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,919 | 495 | N/A | N/A | N/A |
| PPE Investments | -1,463 | -645 | -1,276 | -446 | -229 |
| Purchase Sale Intangibles | -223 | -75 | -523 | -292 | -108 |
| Other Investing Activity | -223 | -75 | -523 | -292 | -108 |
| Investing Cash Flow | $233 | $-225 | $-1,799 | $-738 | $-337 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,550 | 2,500 | 4,500 | 3,500 | 2,500 |
| Debt Repayment | -6,573 | -3,523 | -15,041 | -8,450 | -8,041 |
| Common Stock Issued | 204 | 15 | 930 | 724 | 724 |
| Other Financing Activity | -59 | -47 | -2,523 | -3,792 | -451 |
| Financing Cash Flow | $-878 | $-1,055 | $-12,134 | $-8,018 | $-5,268 |
| Exchange Rate Effect | -147 | -151 | -320 | -137 | 57 |
| Beginning Cash Position | 4,283 | 4,283 | 4,508 | 4,508 | 4,508 |
| End Cash Position | 4,048 | 4,255 | 4,283 | 5,340 | 4,324 |
| Net Cash Flow | $-235 | $-28 | $-225 | $832 | $-184 |
| Free Cash Flow | |||||
| Operating Cash Flow | 557 | 1,403 | 14,028 | 9,725 | 5,364 |
| Capital Expenditure | -1,463 | -645 | -1,788 | -958 | -741 |
| Free Cash Flow | -906 | 758 | 12,240 | 8,767 | 4,623 |